DHR

NYSE · Life Sciences Tools & Services

Danaher Corp

S&P 500 Large-Cap Stocks Blue Chip Stocks Healthcare Stocks Best Dividend Stocks

$190.48

-2.30 (-1.19%)

As of Jun 30, 9:31 PM ET ·

Financial Highlights (FY 2026)

Revenue

24.01B

Net Income

3.53B

Gross Margin

59.2%

Profit Margin

14.7%

Rev Growth

-2.7%

D/E Ratio

0.35

Revenue & Net Income

Margin Trends

	FY 2026	FY 2025	FY 2024	FY 2023
Gross Margin	59.2%	59.2%	33.1%	33.1%
Operating Margin	19.2%	17.3%	22.8%	20.7%
Profit Margin	14.7%	14.0%	16.1%	14.5%

Income Statement

	FY 2026	FY 2025	FY 2024	FY 2023
Revenue	24.01B	24.67B	64.73B	56.82B
Gross Profit	14.22B	14.61B	21.40B	18.79B
Operating Income	4.60B	4.26B	14.74B	11.75B
Net Income	3.53B	3.27B	10.42B	8.26B
Gross Margin	59.2%	59.2%	33.1%	33.1%
Operating Margin	19.2%	17.3%	22.8%	20.7%
Profit Margin	14.7%	14.0%	16.1%	14.5%
Rev Growth	-2.7%	-2.7%	+18.7%	+12.4%

Balance Sheet

	FY 2026	FY 2025	FY 2024	FY 2023
Total Debt	17.82B	17.82B	69.79B	63.61B
Total Equity	50.82B	50.82B	119.38B	109.88B
D/E Ratio	0.35	0.35	0.58	0.58

Cash Flow

	FY 2026	FY 2025	FY 2024	FY 2023
EBITDA	5.34B	5.21B	20.74B	18.10B
Free Cash Flow	—	—	7.59B	7.26B